today announced the Company will exhibit five posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress, which is being held from October 22-25, 2024, in Rome ...
today announced the Company will exhibit five posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress, which is being held from October 22-25, 2024, in Rome ...
As rods outnumber cones by a ratio of 1:20 or greater in the retina and defects are common in rods leading to various ocular diseases, we sought to design and test novel promoters to drive expression ...
SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- Amplo Biotechnology, a biotechnology company developing genetic medicines for the treatment of neuromuscular diseases, announced the presentation of three ...
appointed by a government committed to joining the European Union and leaving Russia’s orbit, was alarmed to find his country’s capital suddenly plastered with posters bearing a blunt message ...
The image of millions of butterflies in a magical forest won the European Wildlife Photographer competition and here are 20 more amazing category winners.
- Initial data from the ongoing Phase 1b study evaluating R289, a dual IRAK1/4 inhibitor, in LR-MDS Initial data from the dose escalation phase using a July 15, 2024 data cutoff date indicate that ...
An image of millions-upon-millions of monarch butterflies covering every inch of a forest is pronounced the overall winner of ...
today announced that preclinical data from the Company’s iPSC-derived cell therapy platform will be presented in five posters at the 2024 ASH Annual Meeting to be held in San Diego, CA from Dece ...
allowing for control of tumors in vivo without the need for exogenous or engineered cytokines – – Posters include demonstration of advances in gene editing and transgene design that enable ...
– Company to share preclinical data across diverse pipeline of iNK, γδ iT, and αβ iT cell therapy programs for oncology and autoimmune disease (AID) – – Preclinical data on development ...
today announced that the company will present two oral presentations and one poster presentation at the 66th American Society of Hematology (ASH) Annual Meeting, being held December 7-10, 2024, in San ...